Mary Beth Klein
- Hematology top 5%
- Epidemiology
- Infectious Diseases top 10%
- Molecular Biology
- Immunology
- Co-authors
- Jun MinowadaNirmala BhoopalamGerhard GaedickeParameswaran VenugopalSefer GezerAzra RazaH. DrexlerJohn P. Matts
- Topics
- Acute Myeloid Leukemia Research (6 papers)Acute Lymphoblastic Leukemia research (3 papers)Infectious Diseases and Tuberculosis (2 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Mary Beth Klein
11 papers receiving 449 citations
Peers
Comparison fields: 5 of 64
- Hematology 237
- Epidemiology 121
- Infectious Diseases 116
- Molecular Biology 110
- Immunology 80
Countries citing papers authored by Mary Beth Klein
This map shows the geographic impact of Mary Beth Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beth Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beth Klein more than expected).
Fields of papers citing papers by Mary Beth Klein
This network shows the impact of papers produced by Mary Beth Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beth Klein. The network helps show where Mary Beth Klein may publish in the future.
Co-authorship network of co-authors of Mary Beth Klein
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Beth Klein. A scholar is included among the top collaborators of Mary Beth Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Beth Klein. Mary Beth Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease. | 10 |
| 2 | 125 | |
| 3 | 156 | |
| 4 | 77 | |
| 5 | Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias. | 9 |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 49 | |
| 9 | 10 | |
| 10 | Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease. | 25 |
| 11 | Chemotherapy of genitourinary tuberculosis with isonicotinic acid hydrazide; preliminary observations. | 4 |
About Mary Beth Klein
Mary Beth Klein is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 11 papers that have together received 472 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers) and Infectious Diseases and Tuberculosis (2 papers). The work is most often cited by research in Hematology (237 citations), Infectious Diseases (116 citations) and Genetics (63 citations). Mary Beth Klein has collaborated with scholars based in United States and Germany. Frequent co-authors include Jun Minowada, Nirmala Bhoopalam, Gerhard Gaedicke, Parameswaran Venugopal, Sefer Gezer, Azra Raza, H. Drexler, John P. Matts, Susan Szabo and Anita Vaughn. Their work appears in journals such as New England Journal of Medicine, Blood and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.